7月16日，全省医保重点工作现场推进会在榆林召开。会议 采取"现场观摩+座谈交流"的形式进行 ， 全面检视上半年医保工作成效 ， 交流互鉴经验， 安排部署下半年任务。省医保局局长苏红英主持会 议并讲话。 会议指出，上半年全省医保系统坚持深化改革、精细管理、优化服务一体推进，各项工作运行稳 健、质效双升。一是改革性任务加快落地。稳妥落地省级调剂金制度，深入推进支付方式改革，全面开 展数据发布，加快落实医疗服务价格项目立项指南，扎实开展年度医疗服务价格动态调整，持续释放改 革红利。二是专项工作有力有效。扎实开展深入贯彻中央八项规定精神学习教育，全面推进医保基金管 理突出问题专项整治，整改完成国家专项审计调查反馈意见，深入开展两定机构违法违规使用基金自查 自纠和药品追溯码打击药品领域欺诈骗保专项行动，着力维护群众"救命钱"安全。三是常态化工作有序 推进。坚持和完善三重保障制度，积极推进"三医"协同发展和治理，持续强化两定机构管理。坚持党建 赋能，持续推进党建工作与医保业务深度融合。四是信息化保障加力突破。首次实现线上年度清算，全 面落地即时结算改革，上线运行省内异地就医纳入就医地结算系统，高效处理地市需求。首次开通 ...

Group 1 - The National Healthcare Security Administration (NHSA) has made significant progress in addressing issues related to the management of medical insurance funds, particularly in combating illegal activities such as the resale of "returned drugs" [1] - "Returned drugs" refer to pharmaceuticals that have exited the legitimate distribution channels and re-entered the market, often through illegal means, posing risks to public health and safety [1] - The NHSA has launched a drug traceability information query function on its platform, allowing pharmacies to identify "returned drugs" through scanning, thereby ensuring the legality of drug sources [1][2] Group 2 - As of now, the NHSA has collected a total of 39.885 billion drug traceability codes to assist in combating the "returned drug" issue [2] - The NHSA plans to enhance the regulatory application of drug traceability codes, focusing on building a big data regulatory model to combat illegal drug trading and other violations [2] - The NHSA has initiated a special action to combat the production and sale of counterfeit and inferior drugs, with the first phase of verification tasks completed and several cases of "returned drugs" being addressed [2]